Andon Health Co., Ltd. (SHE:002432)
China flag China · Delayed Price · Currency is CNY
54.10
+0.92 (1.73%)
Nov 17, 2026, 3:04 PM CST

Andon Health Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
1,1021,3662,5923,23126,3152,397
Revenue Growth
-29.80%-47.32%-19.77%-87.72%997.80%19.36%
Gross Profit
661.04842.211,8071,95620,7861,512
Operating Income
-279.26-324.28677.15752.6618,500919.31
Net Income
5,8832,2671,6691,25216,030908.64
Earnings Per Share
13.925.213.782.7734.302.00
EPS Growth
225.74%37.73%36.73%-91.93%1615.80%257.03%

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '24 Dec '23 Jan '23
Special Equipment Manufacturing Industry
1,1582,4393,09924.43
Internet Medical Products and Services
121.9876.1637.2117.88
New Retail Business
75.4762.9521.6832.27
Unallocated Other Income
9.8513.8560.2748.81
Total
1,3662,5923,23126,315

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
9,05911,57413,63611,38411,7601,343
Total Debt
9,1525,6823,3601,578317.75379.84
Net Cash (Debt)
-93.55,89210,2769,80611,443963.56
Net Cash Growth
--42.66%4.79%-14.30%1087.52%15.94%
Net Cash Per Share
-0.2213.5523.3021.6824.482.12

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
-296.97-166.8986.751,77018,222293.11
Capital Expenditures
-137.43-264.33-73.92-212.65-211.9-70.45
Free Cash Flow
-434.39-431.13912.831,55718,010222.67
Free Cash Flow Growth
---41.39%-91.35%7988.15%-45.41%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
60.00%61.67%69.72%60.54%78.99%63.09%
Operating Margin
-25.35%-23.75%26.12%23.29%70.30%38.35%
Pretax Margin
634.15%185.07%81.28%48.91%69.38%41.70%
Profit Margin
533.95%165.99%64.38%38.74%60.92%37.91%
FCF Margin
-39.43%-31.57%35.22%48.20%68.44%9.29%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
1.6501.6500.2000.3002.5000.700
Dividend Per Share Growth
725.00%725.00%-33.33%-88.00%257.14%1066.67%
Dividend Yield
3.05%4.11%0.49%0.79%5.05%1.38%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
3.897.4211.2814.071.4525.45
Forward PE
-41.1741.1741.8623.66165.57
P/FCF Ratio
--20.6111.301.30103.86
PS Ratio
20.6012.317.265.450.899.65